VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q42608425 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000204.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q42608425‏
024 ‎‡a 0000-0001-5192-8878‏ ‎‡2 orcid‏
024 ‎‡a 22954229200‏ ‎‡2 scopus‏
024 ‎‡a 56637450500‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q42608425‏
100 0 ‎‡a Heng Luo‏ ‎‡9 ast‏ ‎‡9 es‏ ‎‡9 sl‏
400 0 ‎‡a Heng Luo‏ ‎‡c researcher (ORCID 0000-0001-5192-8878)‏ ‎‡9 en‏
400 0 ‎‡a Heng Luo‏ ‎‡c onderzoeker‏ ‎‡9 nl‏
670 ‎‡a Author's A rat RNA-Seq transcriptomic BodyMap across 11 organs and 4 developmental stages‏
670 ‎‡a Author's Applying network analysis and Nebula (neighbor-edges based and unbiased leverage algorithm) to ToxCast data‏
670 ‎‡a Author's Combining Docking Pose Rank and Structure with Deep Learning Improves Protein-Ligand Binding Mode Prediction over a Baseline Docking Approach‏
670 ‎‡a Author's Comparing genetic variants detected in the 1000 genomes project with SNPs determined by the International HapMap Consortium‏
670 ‎‡a Author's Comparison of RNA-seq and microarray-based models for clinical endpoint prediction‏
670 ‎‡a Author's Competitive molecular docking approach for predicting estrogen receptor subtype α agonists and antagonists‏
670 ‎‡a Author's DDI-CPI, a server that predicts drug-drug interactions through implementing the chemical-protein interactome‏
670 ‎‡a Author's Development and Validation of Decision Forest Model for Estrogen Receptor Binding Prediction of Chemicals Using Large Data Sets‏
670 ‎‡a Author's DPDR-CPI, a server that predicts Drug Positioning and Drug Repositioning via Chemical-Protein Interactome‏
670 ‎‡a Author's Drug repositioning for diabetes based on 'omics' data mining‏
670 ‎‡a Author's Estrogenic activity data extraction and in silico prediction show the endocrine disruption potential of bisphenol A replacement compounds‏
670 ‎‡a Author's Exploring off-targets and off-systems for adverse drug reactions via chemical-protein interactome--clozapine-induced agranulocytosis as a case study‏
670 ‎‡a Author's Haystack, a web-based tool for metabolomics research‏
670 ‎‡a Author's HLADR: a database system for enhancing the discovery of biomarkers for predicting human leukocyte antigen-mediated idiosyncratic adverse drug reactions.‏
670 ‎‡a Author's Machine Learning Methods for Predicting HLA-Peptide Binding Activity‏
670 ‎‡a Author's Machine-Learning Prediction of Oral Drug-Induced Liver Injury (DILI) via Multiple Features and Endpoints‏
670 ‎‡a Author's Molecular Docking for Identification of Potential Targets for Drug Repurposing.‏
670 ‎‡a Author's Molecular Docking for Prediction and Interpretation of Adverse Drug Reactions‏
670 ‎‡a Author's Molecular docking to identify associations between drugs and class I human leukocyte antigens for predicting idiosyncratic drug reactions.‏
670 ‎‡a Author's SePreSA: a server for the prediction of populations susceptible to serious adverse drug reactions implementing the methodology of a chemical-protein interactome‏
670 ‎‡a Author's sNebula, a network-based algorithm to predict binding between human leukocyte antigens and peptides‏
670 ‎‡a Author's Understanding and predicting binding between human leukocyte antigens (HLAs) and peptides by network analysis‏
670 ‎‡a Author's Whole genome sequencing of 35 individuals provides insights into the genetic architecture of Korean population‏
909 ‎‡a (scopus) 56637450500‏ ‎‡9 1‏
909 ‎‡a (scopus) 22954229200‏ ‎‡9 1‏
909 ‎‡a (orcid) 0000000151928878‏ ‎‡9 1‏
919 ‎‡a estrogenicactivitydataextractionandinsilicopredictionshowtheendocrinedisruptionpotentialofbisphenolareplacementcompounds‏ ‎‡A Estrogenic activity data extraction and in silico prediction show the endocrine disruption potential of bisphenol A replacement compounds‏ ‎‡9 1‏
919 ‎‡a drugrepositioningfordiabetesbasedonomicsdatamining‏ ‎‡A Drug repositioning for diabetes based on 'omics' data mining‏ ‎‡9 1‏
919 ‎‡a dpdrcpiaserverthatpredictsdrugpositioninganddrugrepositioningviachemicalproteininteractome‏ ‎‡A DPDR-CPI, a server that predicts Drug Positioning and Drug Repositioning via Chemical-Protein Interactome‏ ‎‡9 1‏
919 ‎‡a developmentandvalidationofdecisionforestmodelforestrogenreceptorbindingpredictionofchemicalsusinglargedatasets‏ ‎‡A Development and Validation of Decision Forest Model for Estrogen Receptor Binding Prediction of Chemicals Using Large Data Sets‏ ‎‡9 1‏
919 ‎‡a ddicpiaserverthatpredictsdrugdruginteractionsthroughimplementingthechemicalproteininteractome‏ ‎‡A DDI-CPI, a server that predicts drug-drug interactions through implementing the chemical-protein interactome‏ ‎‡9 1‏
919 ‎‡a competitivemoleculardockingapproachforpredictingestrogenreceptorsubtypeαagonistsandantagonists‏ ‎‡A Competitive molecular docking approach for predicting estrogen receptor subtype α agonists and antagonists‏ ‎‡9 1‏
919 ‎‡a comparisonofrnaseqandmicroarraybasedmodelsforclinicalendpointprediction‏ ‎‡A Comparison of RNA-seq and microarray-based models for clinical endpoint prediction‏ ‎‡9 1‏
919 ‎‡a comparinggeneticvariantsdetectedinthe1000genomesprojectwithsnpsdeterminedbytheinternationalhapmapconsortium‏ ‎‡A Comparing genetic variants detected in the 1000 genomes project with SNPs determined by the International HapMap Consortium‏ ‎‡9 1‏
919 ‎‡a combiningdockingposerankandstructurewithdeeplearningimprovesproteinligandbindingmodepredictionoverabaselinedockingapproach‏ ‎‡A Combining Docking Pose Rank and Structure with Deep Learning Improves Protein-Ligand Binding Mode Prediction over a Baseline Docking Approach‏ ‎‡9 1‏
919 ‎‡a applyingnetworkanalysisandnebulaneighboredgesbasedandunbiasedleveragealgorithmtotoxcastdata‏ ‎‡A Applying network analysis and Nebula (neighbor-edges based and unbiased leverage algorithm) to ToxCast data‏ ‎‡9 1‏
919 ‎‡a ratrnaseqtranscriptomicbodymapacross11organsand4developmentalstages‏ ‎‡A A rat RNA-Seq transcriptomic BodyMap across 11 organs and 4 developmental stages‏ ‎‡9 1‏
919 ‎‡a wholegenomesequencingof35individualsprovidesinsightsintothegeneticarchitectureofkoreanpopulation‏ ‎‡A Whole genome sequencing of 35 individuals provides insights into the genetic architecture of Korean population‏ ‎‡9 1‏
919 ‎‡a understandingandpredictingbindingbetweenhumanleukocyteantigenshlasandpeptidesbynetworkanalysis‏ ‎‡A Understanding and predicting binding between human leukocyte antigens (HLAs) and peptides by network analysis‏ ‎‡9 1‏
919 ‎‡a snebulaanetworkbasedalgorithmtopredictbindingbetweenhumanleukocyteantigensandpeptides‏ ‎‡A sNebula, a network-based algorithm to predict binding between human leukocyte antigens and peptides‏ ‎‡9 1‏
919 ‎‡a sepresaaserverforthepredictionofpopulationssusceptibletoseriousadversedrugreactionsimplementingthemethodologyofachemicalproteininteractome‏ ‎‡A SePreSA: a server for the prediction of populations susceptible to serious adverse drug reactions implementing the methodology of a chemical-protein interactome‏ ‎‡9 1‏
919 ‎‡a moleculardockingtoidentifyassociationsbetweendrugsandclass1humanleukocyteantigensforpredictingidiosyncraticdrugreactions‏ ‎‡A Molecular docking to identify associations between drugs and class I human leukocyte antigens for predicting idiosyncratic drug reactions.‏ ‎‡9 1‏
919 ‎‡a moleculardockingforpredictionandinterpretationofadversedrugreactions‏ ‎‡A Molecular Docking for Prediction and Interpretation of Adverse Drug Reactions‏ ‎‡9 1‏
919 ‎‡a moleculardockingforidentificationofpotentialtargetsfordrugrepurposing‏ ‎‡A Molecular Docking for Identification of Potential Targets for Drug Repurposing.‏ ‎‡9 1‏
919 ‎‡a machinelearningpredictionoforaldruginducedliverinjurydiliviamultiplefeaturesandendpoints‏ ‎‡A Machine-Learning Prediction of Oral Drug-Induced Liver Injury (DILI) via Multiple Features and Endpoints‏ ‎‡9 1‏
919 ‎‡a machinelearningmethodsforpredictinghlapeptidebindingactivity‏ ‎‡A Machine Learning Methods for Predicting HLA-Peptide Binding Activity‏ ‎‡9 1‏
919 ‎‡a hladradatabasesystemforenhancingthediscoveryofbiomarkersforpredictinghumanleukocyteantigenmediatedidiosyncraticadversedrugreactions‏ ‎‡A HLADR: a database system for enhancing the discovery of biomarkers for predicting human leukocyte antigen-mediated idiosyncratic adverse drug reactions.‏ ‎‡9 1‏
919 ‎‡a haystackawebbasedtoolformetabolomicsresearch‏ ‎‡A Haystack, a web-based tool for metabolomics research‏ ‎‡9 1‏
919 ‎‡a exploringofftargetsandoffsystemsforadversedrugreactionsviachemicalproteininteractomeclozapineinducedagranulocytosisasacasestudy‏ ‎‡A Exploring off-targets and off-systems for adverse drug reactions via chemical-protein interactome--clozapine-induced agranulocytosis as a case study‏ ‎‡9 1‏
996 ‎‡2 LC|n 85009596‏
996 ‎‡2 LC|n 2016005819‏
996 ‎‡2 LC|n 2019183648‏
996 ‎‡2 LC|n 2024054601‏
996 ‎‡2 ISNI|0000000390665825‏
996 ‎‡2 ISNI|000000047475485X‏
996 ‎‡2 LC|no2002007915‏
996 ‎‡2 SUDOC|234167459‏
996 ‎‡2 SUDOC|188153675‏
996 ‎‡2 CYT|AC000634688‏
996 ‎‡2 LC|n 85157316‏
996 ‎‡2 DNB|1306326249‏
996 ‎‡2 DNB|136278027‏
996 ‎‡2 DNB|1314805533‏
996 ‎‡2 J9U|987008729440505171‏
996 ‎‡2 CAOONL|ncf10219653‏
996 ‎‡2 ISNI|0000000025419773‏
996 ‎‡2 NTA|379205920‏
996 ‎‡2 DNB|1059928922‏
996 ‎‡2 LC|no2023009674‏
996 ‎‡2 NLR|RU NLR AUTH 770185797‏
996 ‎‡2 ISNI|0000000496889974‏
996 ‎‡2 DNB|1216277311‏
996 ‎‡2 ISNI|0000000433890708‏
996 ‎‡2 DNB|140742654‏
996 ‎‡2 LC|no2023108608‏
996 ‎‡2 NTA|364178744‏
996 ‎‡2 ISNI|0000000119017353‏
996 ‎‡2 SUDOC|233328963‏
996 ‎‡2 J9U|987007329049805171‏
996 ‎‡2 LC|n 2014025988‏
996 ‎‡2 CYT|AC000248855‏
996 ‎‡2 J9U|987007418480805171‏
996 ‎‡2 LC|no2020008002‏
996 ‎‡2 PLWABN|9812423054605606‏
996 ‎‡2 NTA|421076348‏
996 ‎‡2 NTA|331437767‏
996 ‎‡2 J9U|987007400139005171‏
996 ‎‡2 LC|no2017168258‏
996 ‎‡2 DNB|1163542768‏
996 ‎‡2 NTA|416682391‏
996 ‎‡2 DNB|1300089520‏
996 ‎‡2 ISNI|0000000063691057‏
996 ‎‡2 DNB|1309117675‏
996 ‎‡2 CYT|AC000631942‏
996 ‎‡2 BNF|16566506‏
996 ‎‡2 DNB|121991407X‏
996 ‎‡2 ISNI|000000007738498X‏
996 ‎‡2 LC|nb2018005663‏
996 ‎‡2 ISNI|0000000498921181‏
996 ‎‡2 ISNI|0000000074867994‏
996 ‎‡2 CYT|AC000649029‏
996 ‎‡2 ISNI|0000000501161276‏
996 ‎‡2 DNB|1284495957‏
996 ‎‡2 BNF|16949426‏
996 ‎‡2 DNB|1069694053‏
996 ‎‡2 ISNI|0000000063692746‏
996 ‎‡2 LC|no2011062650‏
996 ‎‡2 CYT|AC000635150‏
996 ‎‡2 DNB|119035669‏
996 ‎‡2 NSK|000663521‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏
998 ‎‡a Heng, Luo‏ ‎‡2 PLWABN|9812728699605606‏ ‎‡3 exact name‏